Organigram Global Inc.
Health
Performance
10.0
Risk
Sell
Buy
Curious about the Scores? Learn more.

Organigram Global Inc. stock rating and score history

All changes in ratings, performance and outlook tracked over time.

11.02.2026
Red alert. Risk levels out of control.
01.01.2026
Rock bottom. The fall’s complete, stability nowhere to be found.
01.01.2026
Danger zone. Balance sheet’s flashing red across the board.
30.12.2025
Momentum tanked. Clearly underperforming.
OGI
Organigram Global Inc.
0.92
-2.91%
10.0
Sell
Buy
Organigram Global Inc.

Organigram Global Inc. stock price, chart patterns and momentum

Recent price movements, trend behaviour and momentum signals based on real-time market data.

What does Organigram Global Inc. do? Business model and key facts

Get the full picture of Organigram Global Inc.: what it builds, where it operates, and how it makes money.

Organigram Global Inc. Profile

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Employees (FY): 1139

Organigram Global Inc., primarily operating through its subsidiary Organigram Holdings Inc., is a Canadian enterprise specializing in the cultivation, production, and distribution of cannabis and related products. The company serves the medical cannabis market by offering products such as cannabis flowers, oils, and vaporizing devices to both civilian patients and military veterans. For adult recreational consumers, Organigram provides a diverse range of cannabis products, including edibles and concentrates, under popular brands like Edison Cannabis Co., Trail Blazer, SHRED, SHRED'ems, Big Bag O' Buds, and Monjour. Additionally, the company acts as a wholesale supplier, distributing cannabis plant cuttings, dried flowers, proprietary blends, pre-rolled products, and various cannabis derivatives to retailers and other wholesalers within the adult-use recreational sector. Customers can purchase Organigram's offerings through its online platform or via telephone orders. Established in 2013, the company's corporate headquarters are located in Moncton, Canada.

shop
Company facts
James H. Yamanaka
CEO
1139
Employees worldwide
shop
Performance
-40.82%
Last 12 months
-90.83%
Last 5 years
shop
Growth
$186.09M
Revenue year
$-24,759,000
Net income
shop
Valuation
$126.68M
Market Cap
-14.84
Price/Earnings Ratio

Stocks related to Organigram Global Inc.

Selected based on industry alignment and relative market positioning.

LFCR
Lifecore Biomedical, Inc.
4.58
-1.29%
9.0
Sell
Buy
Lifecore Biomedical, Inc.
EMBC
Embecta Corp.
3.25
-3.56%
8.9
Sell
Buy
Embecta Corp.
SIGA
SIGA Technologies, Inc.
3.39
-5.31%
8.6
Sell
Buy
SIGA Technologies, Inc.
ZYBT
Zhengye Biotechnology Holding Limited
1.38
-51.58%
10.0
Sell
Buy
Zhengye Biotechnology Holding Limited

Events and news impacting Organigram Global Inc. stock

Earnings, coporate decisions and industry developments that can affect the share price.

Organigram Global Inc. fundamentals and technical analysis

Financial fundamentals and technicals signals combined to access stability, momentum and market direction.